Bank of America’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-8,954,700
| Closed | -$228M | – | 8109 |
|
|
2025
Q3 | $228M | Buy |
8,954,700
+336,800
| +4% | +$8.31M | 0.02% | 741 |
|
|
2025
Q2 | $209M | Sell |
8,617,900
-3,140,800
| -27% | -$73.2M | 0.02% | 759 |
|
|
2025
Q1 | $298M | Buy |
11,758,700
+6,242,200
| +113% | +$163M | 0.02% | 565 |
|
|
2024
Q4 | $146M | Sell |
5,516,500
-44,600
| -0.8% | -$1.21M | 0.01% | 829 |
|
|
2024
Q3 | $161M | Buy |
5,561,100
+1,556,400
| +39% | +$45.4M | 0.01% | 826 |
|
|
2024
Q2 | $112M | Buy |
4,004,700
+756,700
| +23% | +$20.8M | 0.01% | 963 |
|
|
2024
Q1 | $90.1M | Sell |
3,248,000
-1,013,800
| -24% | -$28.1M | 0.01% | 1088 |
|
|
2023
Q4 | $123M | Buy |
4,261,800
+1,580,100
| +59% | +$47.8M | 0.01% | 850 |
|
|
2023
Q3 | $89M | Buy |
2,681,700
+490,200
| +22% | +$17.3M | 0.01% | 954 |
|
|
2023
Q2 | $80.4M | Sell |
2,191,500
-367,700
| -14% | -$14.3M | 0.01% | 997 |
|
|
2023
Q1 | $104M | Buy |
2,559,200
+783,500
| +44% | +$33.8M | 0.01% | 925 |
|
|
2022
Q4 | $91M | Sell |
1,775,700
-394,800
| -18% | -$18.9M | 0.01% | 936 |
|
|
2022
Q3 | $95M | Sell |
2,170,500
-173,100
| -7% | -$8.41M | 0.01% | 884 |
|
|
2022
Q2 | $123M | Buy |
2,343,600
+166,400
| +8% | +$8.48M | 0.01% | 788 |
|
|
2022
Q1 | $113M | Sell |
2,177,200
-4,247,400
| -66% | -$220M | 0.01% | 898 |
|
|
2021
Q4 | $379M | Buy |
6,424,600
+5,215,100
| +431% | +$258M | 0.04% | 432 |
|
|
2021
Q3 | $52M | Buy |
1,209,500
+278,400
| +30% | +$12.3M | 0.01% | 1326 |
|
|
2021
Q2 | $36.5M | Sell |
931,100
-215,600
| -19% | -$8.38M | ﹤0.01% | 1595 |
|
|
2021
Q1 | $41.5M | Buy |
1,146,700
+1,068,400
| +1,364% | +$37.9M | ﹤0.01% | 1428 |
|
|
2020
Q4 | $2.88M | Sell |
78,300
-1,186,395
| -94% | -$43.5M | ﹤0.01% | 3625 |
|
|
2020
Q3 | $44M | Sell |
1,264,695
-230,193
| -15% | -$8.07M | 0.01% | 1152 |
|
|
2020
Q2 | $46.4M | Sell |
1,494,888
-223,237
| -13% | -$7.58M | 0.01% | 1059 |
|
|
2020
Q1 | $53.2M | Sell |
1,718,125
-1,221,481
| -42% | -$41.6M | 0.01% | 928 |
|
|
2019
Q4 | $109M | Buy |
2,939,606
+212,908
| +8% | +$7.58M | 0.02% | 721 |
|
|
2019
Q3 | $93M | Buy |
2,726,698
+651,056
| +31% | +$23.7M | 0.01% | 776 |
|
|
2019
Q2 | $85.3M | Buy |
2,075,642
+759,196
| +58% | +$30.1M | 0.01% | 816 |
|
|
2019
Q1 | $53M | Sell |
1,316,446
-776,271
| -37% | -$31.1M | 0.01% | 1069 |
|
|
2018
Q4 | $86.7M | Buy |
2,092,717
+580,332
| +38% | +$24.1M | 0.02% | 743 |
|
|
2018
Q3 | $63.2M | Buy |
1,512,385
+140,604
| +10% | +$5.41M | 0.01% | 959 |
|
|
2018
Q2 | $47.2M | Sell |
1,371,781
-497,699
| -27% | -$17M | 0.01% | 1129 |
|
|
2018
Q1 | $62.9M | Sell |
1,869,480
-2,729,754
| -59% | -$93.8M | 0.01% | 914 |
|
|
2017
Q4 | $158M | Sell |
4,599,234
-92,752
| -2% | -$3.16M | 0.03% | 534 |
|
|
2017
Q3 | $159M | Sell |
4,691,986
-955,451
| -17% | -$30.7M | 0.03% | 559 |
|
|
2017
Q2 | $180M | Buy |
5,647,437
+2,182,517
| +63% | +$68.8M | 0.04% | 457 |
|
|
2017
Q1 | $112M | Sell |
3,464,920
-3,575,905
| -51% | -$113M | 0.02% | 638 |
|
|
2016
Q4 | $217M | Buy |
7,040,825
+1,823,314
| +35% | +$55.7M | 0.05% | 390 |
|
|
2016
Q3 | $168M | Buy |
5,217,511
+228,929
| +5% | +$7.65M | 0.04% | 445 |
|
|
2016
Q2 | $167M | Buy |
4,988,582
+1,234,445
| +33% | +$39.4M | 0.04% | 443 |
|
|
2016
Q1 | $106M | Sell |
3,754,137
-3,712,821
| -50% | -$106M | 0.03% | 582 |
|
|
2015
Q4 | $229M | Sell |
7,466,958
-1,593,858
| -18% | -$50.1M | 0.05% | 355 |
|
|
2015
Q3 | $270M | Buy |
9,060,816
+2,690,440
| +42% | +$86.3M | 0.07% | 302 |
|
|
2015
Q2 | $203M | Buy |
6,370,376
+1,415,100
| +29% | +$46.1M | 0.07% | 317 |
|
|
2015
Q1 | $164M | Sell |
4,955,276
-2,888,276
| -37% | -$91.8M | 0.06% | 356 |
|
|
2014
Q4 | $232M | Sell |
7,843,552
-685,943
| -8% | -$19.7M | 0.08% | 278 |
|
|
2014
Q3 | $239M | Buy |
8,529,495
+1,406,616
| +20% | +$39.5M | 0.08% | 271 |
|
|
2014
Q2 | $201M | Buy |
7,122,879
+1,838,861
| +35% | +$52.4M | 0.06% | 317 |
|
|
2014
Q1 | $161M | Sell |
5,284,018
-206,479
| -4% | -$6.16M | 0.06% | 339 |
|
|
2013
Q4 | $160M | Sell |
5,490,497
-339,177
| -6% | -$9.87M | 0.06% | 336 |
|
|
2013
Q3 | $159M | Sell |
5,829,674
-1,950,216
| -25% | -$53.1M | 0.06% | 311 |
|
|
2013
Q2 | $207M | Buy |
+7,779,890
| New | +$215M | 0.09% | 216 |
|
Other funds holding PFE
VCM
VPM
Bank of America's PFE Position: Q1 2026 in Review
Bank of America reduced its Pfizer (PFE) stake by 4.6% in Q1 2026, selling an estimated $59.5M and leaving 46,545,479 shares worth $1.31B. The position accounts for 0.1% of the portfolio, ranked #200.
Bank of America first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.79B in Q3 2017. 2,942 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Bank of America held 46,545,479 shares of Pfizer worth $1.31B as of Q1 2026.
- Bank of America sold 2,235,713 Pfizer shares in Q1 2026, an estimated $59.5M.
- Pfizer made up 0.1% of Bank of America's portfolio in Q1 2026, its #200 holding.
- Bank of America first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Bank of America's Pfizer position peaked at $4.79B in Q3 2017.
- 2,942 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.